Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
Feb 08, 2017 13:31 pm UTC| Business
SAN RAMON, Calif., Feb. 08, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced the pricing of an...
Andiamo Corporation Begins Viability Study for Second Hydrogen Product
Feb 08, 2017 13:30 pm UTC| Business
LANSING, Mich., Feb. 08, 2017 -- Andiamo Corporation (OTC PINK:ANDI), a Wyoming holding company, is pleased to announce it is beginning a viability study for a second hydrogen based product. The study will encompass...
Coherus Prices Public Offering of Common Stock
Feb 08, 2017 13:30 pm UTC| Business
REDWOOD CITY, Calif., Feb. 08, 2017 -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced the pricing of its underwritten public offering of 5,154,640 shares of its common stock at a price to the public of $24.25...
Feb 08, 2017 13:30 pm UTC| Business
VISTA, Calif., Feb. 08, 2017 -- Omnitek Engineering Corp. (OTCQB:OMTK) today announced the company will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories, based in Fullerton,...
Galectin Therapeutics to Present at BIO CEO & Investor Conference
Feb 08, 2017 13:30 pm UTC| Business
NORCROSS, Ga., Feb. 08, 2017 -- Galectin Therapeutics Inc.(NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.D., the Company’s chief operating...
Feb 08, 2017 13:30 pm UTC| Business
WAKEFIELD, Mass., Feb. 08, 2017 -- Edgewater Technology, Inc. (EDGW)- Shirley Singleton, Chairman, President, and Chief Executive Officer of Edgewater, will explore the possibilities for Digital Transformation in the...
Progenics Pharmaceuticals, Inc. to Participate in February Investor Conferences
Feb 08, 2017 13:30 pm UTC| Business
NEW YORK, Feb. 08, 2017 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other technologies for targeting and treating cancer, today announced that Mark Baker,...